Here, we developed a breast cancer-specific suicide gene circuit (BRAS) that integrates the screened cancer-specific promoters RRM2 and MAFK with a microRNA specific to nontumor cells, utilizing the distinct molecular profiles of tumor and nontumor cells. This evidence concerns the gene RRM2 and cancer.